Skip to main content

Abbott news in 2026: 38 dated events

The latest Abbott event on this page is dated Nov 12, 2026. cardiacrhythmnews.com reported: Abbott gains US FDA approval and CE mark for UltiSynq defibrillation lead.

Public (ABT)Medical Equipment Manufacturing10,000+ employeesabbott.comLinkedIn

Get Abbott's live signals in Claude or ChatGPT, or by API

AskWhat changed at Abbott this week? Use Autobound signals for abbott.com.
Dated events
38
Last 90 days
19
Latest
Nov 12, 2026

Source: Autobound Signal API · 112 signals tracked for Abbott · updated

News · latest 10

Latest Abbott news

  1. Launch
    Abbott gains US FDA approval and CE mark for UltiSynq defibrillation leadAbbott announced that it has received US FDA approval and a CE mark for the UltiSynq defibrillation lead.
  2. Launch
    Abbott Laboratories stock: Product pipeline gains two updatesAbbott Laboratories introduced its Panbio COVID-19/Flu A&B self-test for Canadian families.
  3. Partnership
    Abbott partners with experts to share scientific knowledge on nutritional care for children.Abbott's Similac brand collaborated with the Vietnam Pediatric Association to organize the forum 'Proven Nutrition - Confident Choices for Parents.'
  4. In development
    Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy SystemAbbott announced positive 30-day clinical trial results from the TECTONIC IDE study evaluating its investigational SonicForce Coronary Intravascular Lithotripsy System.
  5. Revenue
    Midday Need to Know: Putin signals Ukraine talks, Abbott cuts outlook & moreAbbott Laboratories reported third-quarter revenue of $13.0 billion.
  6. News
  7. Certification
    Abbott’s Cologuard Plus® Receives CE Mark for Colorectal Cancer Screening in EuropeAbbott announced that its Cologuard Plus test has received CE Mark certification under the European Union's In Vitro Diagnostic Regulation.
  8. In development
    Abbott's Cologuard Plus® Receives CE Mark for Colorectal Cancer Screening in EuropeAbbott plans to introduce its non-invasive colorectal cancer screening test Cologuard Plus in selected European markets following CE mark receipt.
  9. In development
    Abbott CardioMEMS Wins FDA Approval for Patient-Facing App FeaturesAbbott plans to make its CardioGuide HF App and a companion software feature, Dynamic Treatment Plan, available later this year.
  10. In development
    Continuous glucose monitoring is associated with lower mortality in type 2 diabetes with basal insulinAbbott has developed Libre Assist, a new AI-powered feature for its application that estimates how certain foods may affect glucose levels, though it is not yet available in Spain.

Showing 10 of 38 dated events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Abbott with the Signal API

One POST /v1/companies/enrich call with abbott.com returns Abbott news signals (news), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"abbott.com","signal_types":["news"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.

Talk to sales

Same industry

Questions about Abbott news

What is the latest news on Abbott?
The newest event on this page is dated Nov 12, 2026. cardiacrhythmnews.com reported: Abbott gains US FDA approval and CE mark for UltiSynq defibrillation lead. This page lists 38 dated events for Abbott, each with a source link.
What is going on with Abbott?
The 10 latest events on this page cover launch (2), partnership (1), in development (4), revenue (1), news (1) and certification (1). The newest: Nov 12, 2026: Abbott gains US FDA approval and CE mark for UltiSynq defibrillation lead (cardiacrhythmnews.com).

Page updated , the date of the newest row on this page.

Source. News articles about the company, one source link per event.

Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.

Data as of .

How this data is built →Get it from the Signal API →